Skip to main content
Top
Published in: Digestive Diseases and Sciences 9/2019

01-09-2019 | Endoscopy | Original Article

Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence

Authors: Gautam Mankaney, Maged Rizk, Shashank Sarvepalli, Jeannie Bongorno, Ari Garber, Rocio Lopez, John McMichael, Carol A. Burke

Published in: Digestive Diseases and Sciences | Issue 9/2019

Login to get access

Abstract

Background and Aim

We identified patients without medical record evidence of up-to-date colorectal cancer (CRC) screening and sent an invitation letter to self-schedule a colonoscopy without requiring prior primary care or gastroenterologist consultation. The aim of the study was to evaluate the response rate to the letter and factors associated with colonoscopy completion.

Methods

A computer algorithm invited patients not up to date with CRC screening, with an INR < 1.5, and living within 300 miles of the Cleveland Clinic main campus through a letter. Patients scheduled a colonoscopy through a dedicated phone line without any prior physician consultation. Clinical, demographic, and socioeconomic variables were extracted from the EMR through natural language algorithms. We analyzed the percentage of patients who completed a colonoscopy within 6 months of sending the letter and factors associated with colonoscopy completion.

Results

A total of 145,717 letters were sent. 1451 patients were deceased and excluded from analysis. 3.8% (5442) of letter recipients completed a colonoscopy. The strongest factors associated with colonoscopy completion on multivariate analysis included family history of polyps (OR 3.1, 95% CI 2.3, 4.2) or CRC (OR 2.1, 95% CI 1.7, 2.5). Other factors included younger age, male gender, married status, closer distance to endoscopy center, number of visits in the year prior, statin use, and diabetes. There were no immediate procedural complications.

Conclusions

Patient-initiated colonoscopy in response to letter invitation for CRC screening is effective and safe with safeguards established a priori. Consultation with a gastroenterologist or primary care physician is not necessary prior to colonoscopy. To our knowledge, this is the first study to evaluate patient-initiated colonoscopy for CRC cancer screening.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.CrossRef Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.CrossRef
2.
go back to reference Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290–1314.CrossRef Edwards BK, Noone AM, Mariotto AB, et al. Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120:1290–1314.CrossRef
3.
go back to reference National Center for Health Statistics (US). 2016. National Center for Health Statistics (US). 2016.
4.
go back to reference Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.CrossRefPubMedPubMedCentral Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015;121:2281–2285.CrossRefPubMedPubMedCentral
5.
go back to reference Seeff LC, DeGroff A, Joseph DA, et al. Moving forward: using the experience of the CDCs’ colorectal cancer screening demonstration program to guide future colorectal cancer programming efforts. Cancer. 2013;119 Suppl 15:2940–2946.CrossRefPubMed Seeff LC, DeGroff A, Joseph DA, et al. Moving forward: using the experience of the CDCs’ colorectal cancer screening demonstration program to guide future colorectal cancer programming efforts. Cancer. 2013;119 Suppl 15:2940–2946.CrossRefPubMed
6.
go back to reference Grubbs SS, Polite BN, Carney J Jr, et al. Eliminating racial disparities in colorectal cancer in the real world: It took a village. J Clin Oncol. 2013;31:1928–1930.CrossRefPubMedPubMedCentral Grubbs SS, Polite BN, Carney J Jr, et al. Eliminating racial disparities in colorectal cancer in the real world: It took a village. J Clin Oncol. 2013;31:1928–1930.CrossRefPubMedPubMedCentral
7.
go back to reference Dwyer DM, Groves C, Hopkins A, et al. Experience of a public health colorectal cancer testing program in maryland. Public Health Rep. 2012;127:330–339.CrossRefPubMedPubMedCentral Dwyer DM, Groves C, Hopkins A, et al. Experience of a public health colorectal cancer testing program in maryland. Public Health Rep. 2012;127:330–339.CrossRefPubMedPubMedCentral
8.
go back to reference Verma M, Sarfaty M, Brooks D, Wender RC. Population-based programs for increasing colorectal cancer screening in the United States. CA Cancer J Clin. 2015;65:497–510.CrossRefPubMed Verma M, Sarfaty M, Brooks D, Wender RC. Population-based programs for increasing colorectal cancer screening in the United States. CA Cancer J Clin. 2015;65:497–510.CrossRefPubMed
9.
go back to reference Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRefPubMedPubMedCentral Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172:575–582.CrossRefPubMedPubMedCentral
10.
go back to reference ASGE Standards of Practice Committee, Chandrasekhara V, Eloubeidi MA, et al. Open-access endoscopy. Gastrointest Endosc. 2015;81:1326–1329.CrossRef ASGE Standards of Practice Committee, Chandrasekhara V, Eloubeidi MA, et al. Open-access endoscopy. Gastrointest Endosc. 2015;81:1326–1329.CrossRef
11.
go back to reference Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546.CrossRef Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546.CrossRef
12.
go back to reference Guessous I, Dash C, Lapin P, et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50:3–10.CrossRefPubMed Guessous I, Dash C, Lapin P, et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50:3–10.CrossRefPubMed
13.
go back to reference Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668–676.CrossRefPubMed Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668–676.CrossRefPubMed
14.
go back to reference Rathgaber SW, Wick TM. Colonoscopy completion and complication rates in a community gastroenterology practice. Gastrointest Endosc. 2006;64:556–562.CrossRefPubMed Rathgaber SW, Wick TM. Colonoscopy completion and complication rates in a community gastroenterology practice. Gastrointest Endosc. 2006;64:556–562.CrossRefPubMed
15.
go back to reference Myers RE, Bittner-Fagan H, Daskalakis C, et al. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2013;22:109–117.CrossRef Myers RE, Bittner-Fagan H, Daskalakis C, et al. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2013;22:109–117.CrossRef
16.
go back to reference Riggs KR, Segal JB, Shin EJ, Pollack CE. Prevalence and cost of office visits prior to colonoscopy for colon cancer screening. JAMA. 2016;315:514–515.CrossRefPubMed Riggs KR, Segal JB, Shin EJ, Pollack CE. Prevalence and cost of office visits prior to colonoscopy for colon cancer screening. JAMA. 2016;315:514–515.CrossRefPubMed
17.
go back to reference Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72–90.CrossRefPubMed Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72–90.CrossRefPubMed
18.
go back to reference Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin. 2007;57:354–366.CrossRefPubMed Sarfaty M, Wender R. How to increase colorectal cancer screening rates in practice. CA Cancer J Clin. 2007;57:354–366.CrossRefPubMed
Metadata
Title
Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence
Authors
Gautam Mankaney
Maged Rizk
Shashank Sarvepalli
Jeannie Bongorno
Ari Garber
Rocio Lopez
John McMichael
Carol A. Burke
Publication date
01-09-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05584-9

Other articles of this Issue 9/2019

Digestive Diseases and Sciences 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine